The AstraZeneca/Oxford University Phase 3 COVID-19 Vaccine Trial – Why Was It Paused?
by Helen Stillwell Recently, a Phase 3 trial investigating a COVID-19 vaccine (AZD1222) being developed by AstraZeneca and the University of Oxford was put on hold in the US following a report of an adverse event in a study participant in the U.K. (Feuerstein 2020). One of the predominant vaccine candidates against SARS-CoV-2, AZD1222 is […]
Source: virology blog - Category: Virology Authors: Vincent Racaniello Tags: Basic virology Helen Stilwell Information AstraZenca ChAdOx1 COVID-19 Oxford University pandemic SARS-CoV-2 transverse myelitis vaccine viral virus viruses Source Type: blogs
More News: AstraZeneca | Blogging | COVID-19 | Oxford University | Pandemics | SARS | Study | Vaccines | Virology